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Abstract Novel calcium alginate poly(ethylene glycol)
hybrid microspheres (Ca-alg-PEG) were developed and
evaluated as potentially suitable materials for cell micro-
encapsulation. Grafting 5–13% of the backbone units of
sodium alginate (Na-alg) with a-amine-x-thiol PEG
maintained the gelling capacity in presence of calcium
ions, while thiol end groups allowed for preparing chemi-
cally crosslinked hydrogel via spontaneous disulfide bond
formation. The combination of these two gelling mecha-
nisms yielded Ca-alg-PEG. Human hepatocellular carci-
noma cells (Huh-7) were encapsulated in Ca-alg-PEG and
calcium alginate beads (Ca-alg), and cultured for 2 weeks
under agitation conditions. Immediately after completion
of the microencapsulation, the cell viability was 60% and
similar in Ca-alg-PEG and Ca-alg. The proliferation of
Huh-7 encapsulated in Ca-alg-PEG was slightly higher
than in Ca-alg. Accelerated proliferation after 2 weeks was
observed for the encapsulation in Ca-alg-PEG. The pro-
duction of albumin confirmed the functionality of the
encapsulated Huh-7 cells. The study confirms the suit-
ability of Ca-alg-PEG and the one-step technology for cell
microencapsulation.
1 Introduction
Liver tissue engineering with three-dimensional (3D) bio-
materials represents a promising approach for developing
hepatic tissue, which mimics liver functions. Many other
applications would benefit from this approach, ranging
from organ supply to toxicology studies and even virology
[1–3]. It has been shown that 3D culture offers suitable
conditions to induce maturation in fetal hepatocytes, and to
prolong hepatic functions of primary adult hepatocytes
[4–8]. Among the different 3D systems that have been
developed for this purpose, encapsulation of hepatic cells
within hydrogel microspheres is thought to advantageously
meet the requirements for sustained cell viability and
functionality [9–13]. Indeed, the encapsulation of cells
within hydrogels of spherical shape and suitable surface/
volume ratio is representing an interesting alternative to
fiber systems [14, 15] or sandwich cultures [16–18]. The
microencapsulated cells can be perfused within bioreactors
[19–23] with a significant improvement of mass transfer
between the cells and the surrounding fluid. Nevertheless,
progress in the field of cell microencapsulation has been
hampered in particular due to difficulties to maintain cell
viability, insufficient mechanical stability of the hydro-
gels, and biocompatibility issues. Several criteria must be
considered when designing suitable hydrogel micro-
spheres for cell encapsulation. Microspheres intended for
cell encapsulation require sufficient mechanical resistance
and durability to withstand the various forces during
application. In addition, the process by which gelation
occurs must support cell integrity and viability [24]. Care
should also be taken in selecting a suitable preparation
technology. Because cells are suspended in a precursor
solution prior to the encapsulation process, the choice
of precursors is limited to water-soluble components.
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Moreover, precursor solutions must be buffered with
appropriate osmolality to prevent cell lysis, and their
rheological properties have to be carefully controlled to
maintain cell viability and cell–cell contact during the
encapsulation process. For example, mixing cells with
highly viscous solutions can lead to significant decrease in
cell viability because high shear stress can damage cell
membranes [25].
Due to the abundance of sodium alginate (Na-alg), its
favorable gelling properties in presence of divalent cations,
and obvious biocompatibility [26, 27], alginate-based
hydrogels remain the most frequently used materials for
cell immobilization so far reported. Although there is no
doubt about the advantageous properties of Na-alg, the
success of using pure ionically crosslinked alginate gel
networks is uncertain. Indeed, gradual dissolution of such
‘‘physical hydrogel’’ under physiological conditions
remains an issue that needs to be solved. Moreover, fre-
quently used additional coating or reinforcement with
polycations requires multi-step processes and can have an
unwanted negative impact on the biocompatibility. This
was recently demonstrated using a human whole blood
model to evaluate the inflammatory properties of polyca-
tion coated alginate microspheres [28]. As a conclusion
from the state-of-the-art, promising materials should
probably be free of polycations and producible by a simple
technology consisting preferably of only one process step.
Very recent studies report the modification of Na-alg with
biomolecules [29, 30]. In this sense, the modification of
Na-alg for subsequent or simultaneous reinforcement of
ionically crosslinked network by covalent crosslinking has
gained interest and it is being increasingly investigated
[31–35].
Considering the requirements of efficient cell micro-
encapsulation, novel calcium alginate poly(ethylene gly-
col) hybrid microspheres (Ca-alg-PEG) have been
prepared by combining ionotropic gelation of PEG-graf-
ted sodium alginate (Na-alg-PEG) and covalent cross-
linking via disulfide bond formation. Under physiological
conditions, a one-step extrusion process of Na-alg-PEG
into a calcium chloride bath yielded spherical hydrogel of
controllable size. Simultaneously, the more time-con-
suming covalent crosslinking proceeds spontaneously
without additional reagent and reinforces the initially
obtained microspheres. The suitability of Ca-alg-PEG for
cell microencapsulation was investigated by encapsulating
human hepatocellular carcinoma cells (Huh-7). Sustained
viability, proliferation and metabolic activity of the
encapsulated Huh-7 cells were confirmed in vitro. The
conclusions thereof create the basis for novel approaches
to prepare hybrid hydrogels for several applications in the
field of cell microencapsulation.
2 Materials and methods
2.1 Materials
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
sodium citrate, 3-(N-morpholino) propanesulfonic acid
(MOPS), tris(2-carboxyethyl)phosphine) (TCEP), calcium
chloride dihydrate (CaCl2.2H2O), and sodium chloride
(NaCl) were purchased from Sigma (Sigma-Aldrich,
Switzerland). Na-alg (HV Kelton, lot no. 46198 A) was
obtained from Kelco (San Diego, CA, USA). The intrinsic
viscosity [g] in 0.1 M NaCl at 20C and the molar guluronic
acid fraction FG have been analyzed as [g]0.1 M NaCl =
930 ml/g and FG = 0.41. Unless otherwise mentioned, all
reagents were analytical grade and were used without
further purification. The synthesis of Na-alg-PEG was
carried out as described elsewhere [36]. Briefly, Na-alg has
been modified employing aqueous carbodiimide chemistry
to covalently graft a-amine-x-thiol PEG onto the carbox-
ylate groups of the Na-alg backbone. Purification of
Na-alg-PEG was achieved by 4 days dialysis against dis-
tilled water. The degree of grafting, which refers to the
percentage of reacted carboxylate groups, was determined
by 1H-NMR. The same batch of Na-alg was used to prepare
Ca-alg beads and to synthesize Na-alg-PEG.
2.2 Preparation of hydrogels
The gelling capability of Na-alg-PEG following three dif-
ferent approaches was investigated. Spherical physical
hydrogels were prepared by ionotropic gelation of Na-alg-
PEG in presence of calcium ions. The solution was pre-
pared with 2.2 wt% Na-alg-PEG in MOPS stock solution
(10 mM MOPS ? 0.45% NaCl, pH = 7.4) and extruded
directly after complete dissolution into a gelation bath
(150 mM CaCl2 in 10 mM MOPS, pH = 7.4). After
10 min gelation, the spherical physical hydrogels were
collected by filtration, washed twice with MOPS stock
solution, and stored at 4C in the washing solution.
The preparation of chemically crosslinking hydrogel
was achieved via spontaneous disulfide bond formation.
In practice, Na-alg-PEG was dissolved in MOPS stock
solution with a final concentration of 5 wt%. The solution
was vortexed for about 2 min, and the glass vial holding
the solution was placed at 37C under air atmosphere for
72 h.
Hybrid microspheres resulted from the combination of
both gelling mechanisms, the fast ionotropic gelation and
the slow formation of disulfide bonds. This was achieved
by 72 h incubation in MOPS at 37C subsequent to the
extrusion into the CaCl2 bath. Spherical physical hydro-
gels, chemically crosslinked hydrogels, and hybrid
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microspheres will subsequently be designated as PH, CH,
and Ca-alg-PEG, respectively.
2.3 Cell model
Huh-7 cells were obtained from Pr. Duverlie G. (Virology
Laboratory, University Hospital, Amiens, France). Cell
monolayers were cultured at 37C under an atmosphere of
95% air and 5% CO2 in high glucose Dulbecco’s Modified
Essential Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS, Institute of Technology Jacques Boy,
France). The medium was changed three times per week.
The cells were cultured to confluence before microencap-
sulation and were used from passage 5–10.
2.4 Cell microencapsulation
All components used for cell microencapsulation were
dissolved in HEPES solution (10 mM, pH = 7.4). Con-
sidering the humidity of the Na-alg powder, the solution
was prepared with a concentration of 1.5 wt%. The solu-
tion was shaken overnight at 4C for complete dissolution,
sterile filtrated (0.2 lm), and stored at 4C until use.
Na-alg-PEG solution was freshly prepared 2 h before the
microencapsulation process to avoid the formation of
disulfide bonds prior to encapsulation. Na-alg-PEG with a
degree grafting of 5% was used in this study. The solution
was prepared with a concentration of 2.2 wt%, and steril-
ized by filtration (0.2 lm) before use. The gelation bath
was prepared by dissolving 154 mM NaCl and 115 mM
CaCl2 in HEPES solution and sterilization by autoclaving.
Huh-7 cells were removed from T-flasks following trypsin
incubation (Trypsin EDTA in PBS, Institute of Technology
Jacques Boy, France), washed with DMEM, counted, and
centrifuged (1,000 rpm, 5 min). The supernatant was
withdrawn, and the Na-alg stock solution (1.5 wt% in
HEPES) was added to the cell pellet to a final concentration
of 5 9 105 cells/ml of solution. The suspension of cells in
Na-alg was gently homogenized by using a pipette. 10 ml
of the homogeneous suspension was extruded into 100 ml
of the gelation bath employing a coaxial air-flow droplet
generator [37]. The droplets were allowed to gel for
10 min. The microspheres were collected by filtration,
washed twice with DMEM, and finally cultured in DMEM
high glucose supplemented with 10% FBS. An identical
protocol was followed to encapsulate Huh-7 cells within
Ca-alg-PEG microspheres. The sterile solution of Na-alg-
PEG (2.2 wt% in HEPES) was added to cell pellet
(5 9 105 cells/ml), homogenized and extruded. The cells
encapsulated in either Ca-alg-PEG or Ca-alg were trans-
ferred to tissue culture flask 25 cm2 (Grenier Bio-one,
France), maintained at 37C under an atmosphere of 95%
air and 5% CO2, and cultured in hydrodynamic condition
on a rotary plate.
2.5 Cell viability
Cell viability was quantified using the lactate dehydroge-
nase (LDH) assay (Promega, France). The assay monitors
the conversion of nicotinamide adenine dinucleotide
phosphate (NADH) into nicotinamide adenine dinucleotide
(NAD ?) by LDH. The LDH released into the extracellular
medium by damaged cells was expressed as percentage
of the total LDH activity in the cells (% LDH
released = extracellular LDH/(extracellular LDH ? intra-
cellular LDH)). Encapsulated cells were cultured in
DMEM high glucose supplemented with 10% FBS. The
culture medium was changed at days 0, 2, 6, and 13. After
24 h, 50 ll of culture media were withdrawn from the
wells containing the cells within microspheres and placed
in another 96-well plate. Fifty microlitres of the reaction
mixture (LDH Kit) were added to each well. The plate was
then incubated for 30 min at room temperature in the dark.
The absorbance of the samples was monitored at 490 nm
UV/vis spectroscopy (SPECTRAFLUO Plus, TECAN,
Switzerland. To calculate the relative extent of cell death in
the microspheres, 1% Triton X-100 was added in a well
containing the encapsulated cells to lyse all cells in the
microspheres at days 1, 3, and 7. The total amount of LDH
released was then measured. The test was performed in
triplicate (n = 3).
2.6 Cell proliferation
The proliferation of encapsulated Huh-7 cells was quanti-
fied by the Alamar blue assay (Invitrogen, France). The
assay measures the redox capacity of cells due to the
production of metabolites as a result of cell growth. At
days 1, 3, 7 and 14 of culture, 5 ml of 10% (v/v) Alamar
blue dye in DMEM was added to each culture flask. After
1 h incubation (37C, 5% CO2), 100 ll of supernatant was
withdrawn and transferred to 96-well plates. The fluores-
cence was measured by using a spectrophotometer
(SPECTRAFLUO Plus, TECAN, Switzerland) 560 nm
excitation wavelength/590 nm emission wavelength. The
test was performed in triplicate (n = 3).
2.7 Albumin production
At days 1, 2, 3, 7 and 14, samples of the cell culture
medium were withdrawn and frozen for subsequent anal-
ysis of the albumin concentration. A sandwich enzyme-
linked assay determined the albumin concentration as
previously described [12]. Briefly, 96-well plates were
coated with goat antibody against human albumin (Cappel
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Laboratories, Cochrainville, France) overnight at 4C. The
plates were washed, and non-specific interactions were
subsequently blocked. Samples and standards of human
albumin were then placed in wells and incubated for
90 min. The wells were then washed and incubated with an
antibody against human albumin produced in goat and
horseradish peroxidase (HRP) conjugated (Cappel Labo-
ratories, Cochrainville, France). The wells were incubated
after washing, adding H2O2 and substrate o-phenylenedi-
amine dihydrochloride (OPD) for the HRP. The
reaction was stopped by addition of 2 N sulfuric acid
(H2SO4). The absorbance was measured at 490 nm by
spectrophotometry.
3 Results
3.1 Gelation of Na-alg-PEG
The gelling capability of Na-alg-PEG following three dif-
ferent pathways is schematically presented in Fig. 1. First,
the remaining ability of Na-alg-PEG to form hydrogels by
ionotropic gelation in presence of calcium ions was con-
firmed. Upon extrusion of a Na-alg-PEG solution into a
receiving bath containing calcium ions, microspheres of
uniform size, designated here as ‘‘physical hydrogel (PH)’’
were obtained (Fig. 2). Pegylation of up to 13% of
chain units did not affect the ionotropic gelling capacity of
Na-alg-PEG.
Secondly, hydrogel formation by only chemical cross-
linking via disulfide bonds was confirmed when leaving a
solution of Na-alg-PEG at 37C in a glass vial for 72 h.
The ‘‘chemically crosslinked hydrogel (CH)’’ was obtained
with the shape of the vial holding the solution as shown in
Fig. 3. Such CH is not obtainable using unmodified Na-alg.
The reversibility of the resulting CH hydrogel was cor-
roborated. Adding a solution of a reducing agent, in this
study TCEP, cleaved the disulfide bonds and led to the
liquefaction of the CH hydrogel (Fig. 3).
Combining the two mechanisms, fast ionotropic gelation
and slow reinforcement by chemical crosslinking, yielded
Ca-alg-PEG. After 72 h, chemical crosslinking was con-
firmed by incubation of the Ca-alg-PEG microspheres in
Fig. 1 Gelling pathways
of Na-alg-PEG
Fig. 2 Physical hydrogel (PH) obtained by ionotropic gelation
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sodium citrate solution. As visible in Fig. 4, Ca-alg-PEG
kept the spherical shape. Neither deformation nor disso-
lution was observed.
3.2 Cell microencapsulation
The feasibility of the cell entrapment and the suitability of
Ca-alg-PEG for cell microencapsulation were investigated.
A one-step extrusion process under physiological condi-
tions yielded Huh-7 cells encapsulated within Ca-alg and
within the novel Ca-alg-PEG (Fig. 5). No free cells were
identified in the gelation bath after separation of the
microspheres. The average diameters of Ca-alg and Ca-alg-
PEG were 400 and 700 lm. The study was limited to
2 weeks. During this period, the viability of the encapsu-
lated cells, proliferation, and the production of albumin
were investigated.
3.3 Cell viability
Figure 6 presents the results of the viability analyses
toward the LDH assay. The viability of Huh-7 hepatocytes
was first determined immediately after completion of the
microencapsulation as in the range of 55–60%. It increased
with time to reach 65–80% at 7 or 14 days. The cell
viability was similar for both materials Ca-alg-PEG and
Ca-alg at all time points of culture.
3.4 Cell proliferation
The Alamar blue assay allowed for assessing the cell
proliferation within Ca-alg and Ca-alg-PEG. Figure 7
shows the fluorescence intensity over 14 days, which
indicates slight differences between the two types of
hydrogel, the cell growth being slightly superior in Ca-alg-
PEG compared to the control. Moreover, the proliferation
seemed to reach a maximum after 7 days in Ca-alg, while it
continued for Ca-alg-PEG up to 2 weeks.
3.5 Albumin production
The specific functional activity of encapsulated Huh-7 cells
in both types of microspheres was investigated by quanti-
fying the albumin production in the supernatant. Figure 8
shows the amount of albumin released within 24 h nor-
malized to unit of cell metabolic activity. The production
of albumin was similar for both hydrogels.
4 Discussion
Functionalization of the Na-alg carboxylate groups with
heterobifunctional PEG (a-amine-x-thiol PEG) was
achieved via carbodiimide chemistry [36]. The extrusion of
Na-alg-PEG into calcium ions yielded spherical PH. This
reaction confirms that the conjugation of Na-alg with the
PEG pendant side chain did not affect the ionotropic gel-
ling capability of these molecules. However, no spherical
hydrogel was obtained if the degree of grafting exceeded
13%, i.e., if more than every eighth backbone unit was
modified (data not shown). It is suggested that the amount
of remaining free carboxylate groups is then insufficient to
form enough Ca-ionic bridges necessary for a stable PH.
The Na-alg-PEG molecules utilized in this study had a
degree of grafting of 5% ± 0.4, which was sufficient to
form a stable PH but also a stable CH.
Fig. 3 Reversible chemically
crosslinked hydrogel (CH)
obtained via disulfide bond
formation under air atmosphere
Fig. 4 Ca-alg-PEG remained stable and spherical after 24 h
incubation in sodium citrate
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The approach of forming hydrogels via disulfide bond
formation was reported for cell microencapsulation, drug
delivery, and controlled protein release [38–40]. However,
to our knowledge, the preparation of spherical alginate-
based hydrogels with diameters in the micrometer range
via disulfide bond formation was not reported so far.
Because of the spontaneous character of the oxidation
reaction, the preparation of the CH was achievable under
air atmosphere without adding any extra reagent. The
kinetics of this reaction can be influenced by factors such
as temperature, concentration, and oxygen concentration.
So far, the time-consuming reaction (72 h) cannot be
considered as a drawback. The spherical shape of hydrogel
is assured by the initial fast ionotropic gelation of
Na-alg-PEG after contact with Ca2? ions. The advantage is
that the reinforcement is achieved here without addition of
polycations and without any other layering procedure.
Ca-alg-PEG was obtained by combining the two
gelling mechanisms. The integrity and the sphericity of
Ca-alg-PEG were maintained after 24 h incubation in
sodium citrate used as calcium chelating agent. Our previ-
ous studies have shown that 10 min incubation in sodium
citrate solution was sufficient to liquefy the hydrogel net-
work prepared from unmodified Na-alg [35]. This obser-
vation confirms that efficient cross-linking via disulfide
bond formation was achieved. Such crosslinking will cer-
tainly improve the durability of the Ca-alg-PEG if long-term
uses in bioreactors or in vivo applications are intended.
Fig. 5 Microphotographs of encapsulated Huh-7 cells within (top) Ca-alg and (bottom) Ca-alg-PEG. Microphotographs were taken (from left to
right) at days 1, 7 and 14 applying the same magnification
Fig. 6 The viability of encapsulated Huh-7 cells determined by the
LDH assay. Values were normalized to the total number of cells
Fig. 7 Proliferation of encapsulated Huh-7 cells over 2 weeks
evaluated by the Alamar blue assay
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Huh-7 cells were encapsulated within Ca-alg and Ca-
alg-PEG in a one-step extrusion process under physiolog-
ical conditions (pH, temperature). For both hydrogels, the
average diameter was tunable modifying the encapsulation
conditions such as syringe diameter, extrusion rate, and/or
airflow. The final average diameter was different when
comparing both systems despite an identical microencap-
sulation protocol was followed. The pegylation of alginate
led to improvement of the solubility of the polymer and
consequently a reduction of the viscosity of the resulting
solution. The extrusion of lower viscosity solutions yielded
larger droplets, and thus, a larger average diameter upon
gelation. Moreover, the PEG network could act as a spacer
between alginate backbones. It therefore could reduce
shrinkage of the droplets upon gelation, reported for algi-
nate hydrogels [41]. This hydrogel shrinkage may create a
mechanical stress on cells which can influence their via-
bility during the microencapsulation process. In addition,
the high degree of swelling of the hydrophilic PEG net-
work could also have an impact on the final diameter of the
microspheres. Nevertheless, both hydrogel types exhibit a
stable size over time.
Cell viability was about 60% at day 1. This reduced
viability was most likely due to the cell handling and/or
encapsulation procedure, and not to the nature of the hybrid
cross-linking. No significant difference was detected
between Ca-alg and Ca-alg-PEG, suggesting that the for-
mation of the PEG links via disulfide bonds did not neg-
atively affect the cell survival. This finding was confirmed
when studying the viability of encapsulated Huh-7 hepa-
tocytes within Ca-alg-PEG over time. The viability did not
decrease during the 3 days post microencapsulation, which
was the required reaction time to complete the chemical
PEG network, and improved until 14 days of incubation to
reach around 75%. In other words, acceptable cell viability
was obtained regardless the nature of the hydrogel material
used.
Huh-7 cells encapsulated within Ca-alg-PEG continued
proliferation up to 14 days, suggesting no detrimental
effect of the encapsulation procedure on the ability of cells
to proliferate. Ca-alg-PEG thus offered appropriate envi-
ronment for cell proliferation, slightly better than Ca-alg.
Cells encapsulated in Ca-alg-PEG form multicellular
structures and spheroid aggregates (cluster). The size of
these aggregates increased over 7 days of culture indicat-
ing cell proliferation, and then stabilized until 14 days.
Besides the survival and proliferation, albumin produc-
tion by encapsulated Huh-7 cells continued, similar
secretion of albumin within Ca-alg-PEG and Ca-alg was
observed and. This production remained almost constant
over time, up to 2 weeks.
The hydrogel chemically crosslinked with PEG seems
to respond to limitations of alginate used alone for cell
microencapsulation. The mechanical robustness of Ca-alg-
PEG allows a physical protection for beads against shear
stress as it is observed in fluidized bed bioartificial livers.
In this bioreactor, plasma from the patient would be
perfused through a column hosting encapsulated hepato-
cytes. The stable porosity over time of the hydrogel
material could be a guarantee for an efficient immuno-
isolation [23]. This immune property is also required
during long-term transplantation of encapsulated xeno-
genic cells or tissues.
5 Conclusions
With the aim to extend the materials basis for cell micro-
encapsulation, we prepared novel hybrid microspheres
from modified alginate molecules and studied the suit-
ability of these microspheres for cell microencapsulation.
The goal to obtain stable microspheres in a one-step pro-
cess and without incorporation of polycations was
achieved. It was found that Na-alg-PEG maintained the
gelling capacity in presence of divalent cations, while the
free thiol end groups allowed for simultaneous chemical
crosslinking. This chemical crosslinking offers higher sta-
bility and durability upon exposition of the hydrogel to a
chelating agent.
Overall, cell viability, proliferation and albumin secre-
tion confirmed the suitability of Ca-alg-PEG for the
microencapsulation of Huh-7 cells. The results were sim-
ilar as for Ca-alg, which was included in the study for
comparison and due to its known good biocompatibility.
Remaining open questions concerning the durability of
Ca-alg-PEG in long-term culture, mechanical resistance to
shear stress in a bioreactor, and the suitability to encap-
sulate other cells are under investigation.
Fig. 8 Production of albumin by Huh-7 cells encapsulated within
Ca-alg and Ca-alg-PEG
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